Abstract
Upon engagement of the B Cell Receptor (BCR) of WEHI 231 immature B cells, a drop in c-Myc expression is followed by activation of the cyclin-dependent kinase inhibitor (CKI) p27Kip1, which induces growth arrest and apoptosis. Here, we report inverse patterns of p27 and c-Myc protein expression follow BCR engagement. We present evidence demonstrating, for the first time, that the p27Kip1 gene is a target of transcriptional repression by c-Myc. Specifically, the changes in p27 protein levels correlated with changes in p27 mRNA levels, and gene transcription. Induction of p27 promoter activity followed BCR engagement of WEHI 231 cells, and this induction could be repressed upon co-transfection of a c-Myc expression vector. Inhibition of the TATA-less p27 promoter by c-Myc was also observed in Jurkat T cells, vascular smooth muscle, and Hs578T breast cancer cells, extending the observation beyond immune cells. Consistent with a putative Inr element CCAGACC (where +1 is underlined) at the start site of transcription in the p27 promoter, deletion of Myc homology box II reduced the extent of repression. Furthermore, enhanced repression was observed upon transfection of the c-Myc ‘super-repressor’, with mutation of Phe115 to Leu. The sequences mediating transcriptional activity and c-Myc repression were mapped to bp −20 to +20 of the p27 gene. Finally, binding of Max was shown to facilitate c-Myc binding and repression of p27 promoter activity. Overall, these studies identify the p27 CKI gene as a new target whereby c-Myc can control cell proliferation, survival and neoplastic transformation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Amati B, Brooks MW, Levy N, Littlewood TD, Evan GI, Land H . 1993 Cell 72: 233–245
Amundson SA, Zhan Q, Penn LZ, Fornace AJ . 1998 Oncogene 17: 2149–2154
Arsura M, Hofmann CS, Golay J, Introna M, Sonenshein GE . 2000 Blood 96: 1013–1020
Arsura M, Deshpande A, Hann SR, Sonenshein GE . 1995 Mol. Cell. Biol. 15: 6702–6709
Arsura M, Sonenshein G.E . 2001 Transcription Factors: Normal and Malignant Development of Blood Cells Ravid K and Licht J . (eds) J. Wiley & Sons pp521–549
Bellas RE, Lee JS, Sonenshein GE . 1995 J. Clin. Invest. 96: 2521–2527
Benhamou L, Cazenave P-A, Sarthou P . 1990 Eur. J. Immunol. 20: 1405–1407
Berns E, van Putten KJW, van Staveren I, Portengen H, Foekens J . 1992 Cancer Res. 52: 1107–1113
Besancon F, Atfi A, Gespach C, Cayre YE, Bourgeade MF . 1998 Proc. Natl. Acad. Sci. USA 95: 8081–8086
Bond J, Farmer SR . 1983 Mol. Cell. Biol. 3: 1333–1342
Borg A, Baldetorp B, Ferno M, Olsson H, Sigurdsson H . 1992 Eur. J. Cancer 51: 687–691
Bouchard C, Thieke K, Maier A, Saffrich R, Hanley-Hyde J, Ansorge W, Reed S, Sicinski P, Bartek J, Eilers M . 1999 EMBO J. 18: 5321–5333
Boyd A, Schrader J . 1981 J. Immunol. 126: 2466–2469
Catzavelos C, Bhattacharya N, Ung YC, Wilson JA, Roncari L, Sandhu C, Shaw P, Yeger H, Morava-Protzner I, Kapusta L, Franssen E, Pritchard KI, Slingerland JM . 1997 Nature Med. 3: 227–230
Chen D, Krasinski K, Sylvester A, Chen J, Nisen PD, Andres V . 1997 J. Clin. Invest. 99: 2334–2341
Clark HM, Yano T, Otsuki T, Jaffe ES, Shibata D, Raffeld M . 1994 Cancer Res. 54: 3383–3386
Classen GF, Hann SR . 1999 Oncogene 18: 2925–2933
Classen GF, Hann SR . 2000 Proc. Natl. Acad. Sci. USA 97: 9498–9503
Dang CV . 1999 Mol. Cell. Biol. 19: 1–11
Dignam JD, Martin PL, Shastry BS, Roeder RG . 1983 Methods Enzymol. 101: 582–598
Dmitrovsky E, Kuehl WM, Hollis GF, Kirsch IR, Bender TP, Segal S . 1986 Nature 322: 748–750
Ezhevsky S, Toyoshima H, Hunter T, Scott D . 1996 Mol. Biol. Cell 7: 553–564
Facchini LM, Penn LZ . 1998 FASEB J. 12: 633–651
Facchini LM, Chen S, Marhin WW, Lear JN, Penn LZ . 1997 Mol. Cell Biol. 17: 100–114
FitzGerald MJ, Arsura M, Bellas RE, Yang W, Wu M, Chin L, Mann KK, DePinho RA, Sonenshein GE . 1999 Oncogene 18: 2489–2498
Frangioni JV, Neel BG . 1993 Anal. Biochem. 210: 179–187
Gallo R, Padurean A, Jayaraman T, Marx S, Roque M, Adelman S, Chesebro J, Fallon J, Fuster V, Marks A, Badimon JJ . 1999 Circulation 99: 2164–2170
Grandori C, Eisenman RN . 1997 Trends Biochem. Sci. 22: 177–181
Greenberg ME, Ziff EB . 1984 Nature 311: 433–438
Hackett AJ, Smith HS, Springer EL, Owens RB, Nelson-Rees WA, Riggs JL, Gardner MB . 1977 J. Nat. Cancer Inst. 58: 1795–1806
Hann SR, Dixit V, Sears RC, Sealy L . 1994 Genes Dev. 8: 2441–2452
Hengst L, Reed SI . 1996 Science 271: 1861–1864
Hoang A, Lutterbach B, Lewis BC, Yano T, Chou T, Barrett J, Raffeld M, Hann SR, Dang CV . 1995 Mol. Cell. Biol. 15: 4031–4042
Hopewell R, Ziff EB . 1995 Mol. Cell Biol. 15: 3470–3478
Iritani BM, Eisenman RN . 1999 Proc. Natl. Acad. Sci. USA 96: 13180–13185
Kamesaki H, Nishizawa K, Michaud GY, Cossman J, Kiyono T . 1998 J. Immunol. 160: 770–777
Kihara-Newgishi F, Yamada T, Kubota Y, Kondah N, Yamamoto H, Abe M, Shirai T, Hashimoto Y, Oikawa T . 1998 Int. J. Cancer 18: 523–530
Kim M, Katayose Y, Li Q, Rakkar AN, Li Z, Hwang SG, Katayose D, Trepel J, Cowan KH, Seth P . 1998 Biochem. Biophys. Res. Commun. 253: 672–677
Kortylewski M, Heinrich PC, Mackiewicz A, Schniertshauer U, Klingmuller U, Nakajima K, Hirano T, Horn F, Behrmann I . 1999 Oncogene 18: 3742–3753
Kwon T, Nagel J, Bucholz M, Nordin A . 1996 Gene 180: 113–120
Kypreos KE, Marhamati DJ, Sonenshein GE . 1999 Matrix Biology 18: 275–285
Land H, Chen AC, Morgenstern JP, Parada LF, Weinberg RA . 1986 Mol. Cell Biol. 6: 1917–1925
Lee CC, Ichihara T, Yamamoto S, Wanibuchi H, Sugimura K, Wada S, Kishimoto T, Fukushima S . 1999 Carcinogenesis 20: 1697–1708
Lee LA, Dang CV . 1997 Curr. Topics Micro. Immunol. 224: 131–135
Lee H, Arsura M, Wu M, Duyao M, Buckler AJ, Sonenshein GE . 1995 J. Exp. Med. 181: 1169–1177
Lee LA, Dolde C, Barrett J, Wu CS, Dang CV . 1996 J. Clin. Investig. 97: 1687–1695
Lee TC, Li L, Philipson L, Ziff EB . 1997 Proc. Natl Acad Sci USA 94: 12886–12891
Lemaitre J-M, Buckle RS, Mechali M . 1996 Adv. Cancer Res. 70: 95–144
Levine RA, McCormack JE, Buckler AJ, Sonenshein GE . 1986 Mol. Cell Biol. 6: 4112–4116
Li LH, Nerlov C, Prendergast G, MacGregor D, Ziff EB . 1994 EMBO J. 17: 4070–4079
Lioyd RV, Erickson LA, Lin L, Kulig E, QianX, Cheville JC, Scheithauer BW . 1999 Am J. Path. 154: 313–323
Lo K, Smale ST . 1996 Gene 182: 13–22
Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Dratta GF, Jessup JM, Pagano M . 1997 Nature Med. 3: 231–234
Maheswaran S, McCormack JE, Sonenshein GE . 1991 Oncogene 6: 1965–1971
Mai S, Martensson IL . 1995 Nucleic Acids Res. 23: 1–9
Manzano-Winkler R, Novina CD, Roy AL . 1996 J. Biol. Chem. 271: 12076–12081
Mateyak MK, Obaya AJ, Adachi S, Sedivy JM . 1997 Cell Growth Differ. 8: 1039–1048
Mateyak MK, Obaya AJ, Sedivy JM . 1999 Mol. Cell. Biol. 19: 4672–4683
McCormack JE, Pepe VH, Kent RB, Dean M, Marshak-Rothstein A, Sonenshein GE . 1984 Proc. Natl. Acad. Sci. USA 81: 5546–5550
Mink S, Mutschler B, Weiskirchen R, Bister K, Klempnauer KH . 1996 Proc. Natl. Acad. Sci. USA 93: 6635–6640
Norvell A, Mandik L, Monroe JG . 1995 J. Immunol. 154: 4403–4413
Perez-Roger I, Kim SH, Griffiths B, Sewing A, Land H . 1999 EMBO J. 18: 5310–5320
Peukert K, Staller P, Schneider A, Carmichael G, Hanel F, Eilers M . 1997 EMBO J. 16: 5672–5686
Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A . 1994 Genes Dev. 8: 9–22
Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, Daling JR, Roberts JM . 1997 Nature Med. 3: 222–225
Prochownik EV, Kukowska J, Rodgers C . 1988 Mol. Cell. Biol. 8: 3683–3695
Roy AL, Garruthers C, Gutjahr T, Roeder RG . 1993 Nature 365: 359–361
Runge D, Runge DM, Bowen WC, Locker J, Michalopoulos GK . 1997 J. Biol. Chem. 378: 873–881
Schauer SL, Wang Z, Sonenshein GE, Rothstein TL . 1996 J. Immunol. 157: 81–86
Schauer SL, Bellas RE, Sonenshein GE . 1998 J. Immunol. 160: 4398–4405
Sherr C, Roberts JM . 1999 Genes Dev. 13: 1501–1512
Shiyanov P, Hayes S, Chen N, Pestov D, Lau L, Raychaudhuri P . 1997 Mol. Biol. Cell. 8: 1815–1827
Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM, Sonenshein GE . 1997 J. Clin. Invest. 100: 2952–2960
Spencer CA, Groudine M . 1991 Adv. Cancer Res. 56: 1–48
Stanton L, Watt R, Marcu K . 1983 Nature 303: 401–406
Steiner P, Rudolph B, Muller D, Eilers M . 1996 Prog. Cell Cycle Res. 2: 73–82
Tanner FC, Yang ZY, Duckers E, Gordon D, Nabel GJ, Nabel EG, Thompson EB . 1998 Circ. Res. 82: 396–403
Thompson EB . 1998 Annu. Rev. Physiol. 60: 575–600
Toyoshima H, Hunter T . 1994 Cell 78: 67–74
Tsihlias J, Kapusta L, Slingerland J . 1999 Annu. Rev. Med. 50: 401–423
Tsuchiya A, Zhang GJ, Kanno M . 1999 J. Surg. Oncol. 70: 230–234
Vlach J, Hennecke S, Alevizopoulos K, Conti D, Amati B . 1996 EMBO J. 15: 6595–6604
Xiao Q, Claasen G, Shi J, Adachi S, Sedivy J, Hann S . 1998 Genes Dev. 12: 3803–3808
Wang W, Wykrzykowska J, Johnson T, Sen R, Sen J . 1999 J. Immunol. 162: 314–322
Warner BJ, Blain SW, Seoane J, Massague J . 1999 Mol. Cell. Biol. 19: 5913–5922
Warner GL, Ludlow J, Nelson DO, Gaur A, Scott D . 1992 Cell Growth Differ. 3: 175–181
Wu M, Arsura M, Bellas RE, FitzGerald MJ, Lee H, Schauer SL, Sherr DH, Sonenshein GE . 1996a Mol. Cell. Biol. 16: 5015–5025
Wu M, Bellas RE, Shen J, Sonenshein GE . 1998 J. Exp. Med. 187: 1671–1679
Wu M, Bellas RE, Shen J, Yang W, Sonenshein GE . 1999 J. Immunol. 163: 6530–6535
Wu M, Lee H, Bellas RE, Schauer SL, Arsura M, Katz D, FitzGerald MJ, Rothstein TL, Sherr DH, Sonenshein GE . 1996b EMBO J. 15: 4682–4690
Yanagisawa K, Kosaka A, Iwahana H, Nakanishi M, Tominaga S . 1999 J. Biochem. (Tokyo) 125: 36–40
Yano T, Sander C, Clark H, Dolezal M, Jaffe E, Raffeld M . 1993 Oncogene. 8: 2741–2748
Yi AK, Hornbeck P, Lafrenz DE, Krieg AM . 1996 J. Immunol. 157: 4918–4925
Acknowledgements
We thank Drs C Dang, S Desiderio, S Hann, A Koff, Y Xiong, and E Ziff for generously providing cloned DNAs or antibody preparations. This work was supported by National Institutes of Health grants CA 36355 (GE Sonenshein), HL13262 (GE Sonenshein), and CA 82742 (GE Sonenshein) and training grants HL07429 (W Yang) and CA64070 (MJ FitzGerald), and Department of Army grant DAMD17-98-1-8034 (DW Kim) and Cure for Lymphoma Foundation (M Arsura).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yang, W., Shen, J., Wu, M. et al. Repression of transcription of the p27Kip1 cyclin-dependent kinase inhibitor gene by c-Myc. Oncogene 20, 1688–1702 (2001). https://doi.org/10.1038/sj.onc.1204245
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204245
Keywords
This article is cited by
-
NIPSNAP1 directs dual mechanisms to restrain senescence in cancer cells
Journal of Translational Medicine (2023)
-
MiR-138 is a potent regulator of the heterogenous MYC transcript population in cancers
Oncogene (2022)
-
CREB1 contributes colorectal cancer cell plasticity by regulating lncRNA CCAT1 and NF-κB pathways
Science China Life Sciences (2022)
-
miR-190 promotes malignant transformation and progression of human urothelial cells through CDKN1B/p27 inhibition
Cancer Cell International (2021)
-
MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies
Journal of Hematology & Oncology (2021)